Back
Minerva Neurosciences Vs. REV Group Industry Stock Comparison
Sell
22
NERV
Minerva Neurosciences
Last Price:
$1.65
Seasonality Move:
11.16%
Buy
77
REVG
REV Group
Last Price:
$48.45
Seasonality Move:
8.66%
Sell
22
Minerva Neurosciences (NERV)
is a Sell
Is Minerva Neurosciences a Buy, Sell or Hold?
-
The current Minerva Neurosciences [NERV] share price is $1.68. The Score for NERV is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
NERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NERV Stock Price Chart
What is Minerva Neurosciences's stock price today?
-
The Minerva Neurosciences share price today is $1.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NERV is experiencing slight buying pressure.
REVG Stock Price Chart
NERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 47.96 | Sell |
Chaikin Money Flow: | 599 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.68 - 1.82) | Sell |
Bollinger Bands (100): | (1.53 - 1.81) | Buy |
REVG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.9 | Buy |
Relative Strength Index (14 RSI): | 66.78 | Buy |
Chaikin Money Flow: | -105726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44 - 48.58) | Buy |
Bollinger Bands (100): | (29.95 - 42.85) | Buy |
NERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.67 | Buy |
20-day SMA: | 1.74 | Sell |
50-day SMA: | 1.67 | Buy |
200-day SMA: | 2.01 | Sell |
8-day EMA: | 1.06 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.25 | Buy |
200-day EMA: | 0.07 | Buy |
REVG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.31 | Sell |
20-day SMA: | 46.68 | Buy |
50-day SMA: | 41.64 | Buy |
200-day SMA: | 33.53 | Buy |
8-day EMA: | 31.07 | Buy |
20-day EMA: | 16.19 | Buy |
50-day EMA: | 7.26 | Buy |
200-day EMA: | 1.93 | Buy |
Minerva Neurosciences Earnings Growth & NERV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.38 per share, and an increase next year of $0.80 per share.
REV Group Earnings Growth & REVG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.29 per share, an increase this year of $0.86 per share, and an increase next year of $0.94 per share.
Minerva Neurosciences Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
REV Group Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |